Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

ETX.L News

Tuesday broker round-up
23 Oct 2012

Tuesday broker round-up

Aggreko: UBS cuts target from 2,750p to 2,550p, buy rating kept. ARM Holdings: Investec keeps buy rating and 800p target. Avacta: Panmure Gordon kee...

Monday broker round-up - UPDATE
22 Oct 2012

Monday broker round-up - UPDATE

888 Holdings: Morgan Stanley ups target from 125p to 130p, overweight rating kept. Aggreko: Jefferies cuts target from 2,800p to 2,535p, buy rating k...

e-therapeutics produces mixed interims
22 Oct 2012

e-therapeutics produces mixed interims

e-therapeutics, a drug discovery and development company, produced mixed interims with slightly increased losses, but reported progress on its lead ca...

Bramson vehicle buys more shares in F&C
15 Mar 2011

Bramson vehicle buys more shares in F&C

F&C Asset Management chairman Edward Bramson's investment vehicle SIGA LP has acquired more shares in the asset management company. Bramson was appo...

Wife of outgoing FD sells British Land shares
14 Mar 2011

Wife of outgoing FD sells British Land shares

Diane Roberts, the wife of British Land finance director Graham Roberts, has raised more than £1m by selling more than three-quarters of the couple's ...

Shaftesbury boss invests £100,000
4 Mar 2011

Shaftesbury boss invests £100,000

Shaftesbury chief executive Jonathan Lane has invested a further £100,000 in the property investor. Lane has bought 22,222 shares at 450p each. That...

UK SMALLCAP ROUNDUP: E-Therapeutics Seeks Pharma Alliances
29 Jun 2010

UK SMALLCAP ROUNDUP: E-Therapeutics Seeks Pharma Alliances

Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps E-T...

INTERVIEW: E-Therapeutics Readies Trials, Seeks Alliances
29 Jun 2010

INTERVIEW: E-Therapeutics Readies Trials, Seeks Alliances

By Jason Douglas Of DOW JONES NEWSWIRES LONDON (Dow Jones)--U.K. drug developer e-Therapeutics PLC (ETX.LN) Tuesday said its focus this year a...